Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice

International Journal of Cancer

Volumn 117, Issue 5, 2005, Pages 709-717

  Das, Mukul ^a   Ansari, Kausar M ^a   Dhawan, Alok ^a   Shukla, Yogeshwer ^a   Khanna, Subhash K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Argemone oil; Carcinogenesis; DNA damage; Epidemic dropsy; Sanguinarine

Indexed keywords

ALLYL ISOTHIOCYANATE; ARGEMONE OIL; DIMETHYLBENZ[A]ANTHRACENE; DNA; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; INTERCALATING AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21; PROTEIN P53; SANGUINARINE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CHEMICAL CARCINOGENESIS; CLINICAL FEATURE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; ENVIRONMENTAL FACTOR; EPIDEMIC DROPSY; FEMALE; FOOD POISONING; GALLBLADDER CARCINOMA; GENOTOXICITY; HISTOPATHOLOGY; HORMONAL CARCINOGENESIS; HUMAN; INDIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CARCINOGENS; COMET ASSAY; DNA DAMAGE; EDEMA; FEMALE; HUMANS; INDIA; ISOQUINOLINES; MALE; MICE; PLANT OILS;

EID: 27744506832     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21234     Document Type: Article

References (51)

1. Khan JS. Blended mustard oil for health benefits. In: Bhatnagar AK, Singh AK, Prakash S, eds. Health and dietary aspects of mustard oil. New Delhi: Mustard Research and Promotion Consortium, 2001. p 132-8.
2. Das M, Khanna SK. Clinicoepidemiological, lexicological, and safety evaluation studies on argemone oil. Crit Rev Toxicol 1997;27:273-97.
3. Sarkar SL. Katakar oil poisoning. Indian Med Gaz 1926;61:62-3.
4. Lal RB, Roy SC. Investigation into epidemiology of Epidemic Dropsy. I. Introductory notes and historical survey. Indian Med Gaz 1937;25:163-7.
5. Chopra RN, Pasricha CL, Goyal RK, Lal S, Sen AK. The experimental production of syndrome of epidemic dropsy in man. Indian Med Gaz 1939;74:193-8.
6. Sainani GS. Epidemic dropsy. In: Ahuja MMS, ed. Progress in clinical medicine in India. 1st ed. New Delhi: Arnold Heineman, 1976. p 92-105.
7. Das M, Khanna SK. Epidemic dropsy. The National Med J Ind 1998;11:207-8.
8. Chaudhuri RN. Clinical and experimental research. Bull Cal School Trop Med 1959;7:157-65.
9. Das M, Babu K, Reddy N P and Srivastava L M. Oxidative damage of plasma proteins and lipids in epidemic dropsy patients: alterations in antioxidant status. Biochim Biophys Acta 2005;1722:209-11.
10. Das M, Upreti KK, Khanna SK. Biochemical toxicology of argemone oil: role of reactive oxygen species in iron catalyzed lipid peroxidation. Bull Environ Cont Toxicol 1991;46:422-30.
11. Upreti KK, Das M, Khanna SK. Role of antioxidants and scavengers on argemone oil induced toxicity. Arch Environ Contam Toxicol 1991;20:531-7.
12. Sarkar SN. Isolation from argemone oil of dihydrosanguinarine and sanguinarine, toxicity of sanguinarine. Nature 1948;162:265-6.
13. Jagannath P. Cancer Registry, Tata Memorial Hospital, Mumbai, 1992.
14. Vij JC, Govil A, Chaudhary A, Gulati R, Mehta S, Ganguli S. Endoscopic biliary endo prosthesis for palliation of gall bladder carcinoma. Gastrointest Endosc 1996;43:121-3.
15. Perchellet JP, Perchellet EM. Antioxidants and multistage carcinogenesis in mouse skin. Free Red Biol Med 1989;7:377-408.
16. Upreti KK, Das M, Khanna SK. Biochemical toxicology of argemone oil: effect on hepatic cytochrome P-450 and xenobiotic metabolizing enzymes. J Appl Toxicol 1991;11:203-9.
17. Tandon S, Das M, Khanna SK. Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: role of Na+-K+; ATPase. Nat Toxin 1993;1:835-40.
18. Skimkim MB, Andervont HB. Comparative carcinogenicity of three carcinogenic hydrocarbons. J Natl Cancer Inst 1940;1:57-62.
19. Das M, Bickers DR, Mukhtar H. Protection against chemically induced skin tumorigenesis in SENCAR mice by tannic acid. Int J Cancer 1989;43:468-70.
20. Rutenberg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug H, Seligman AM. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 1969;17:517-20.
21. Wechestein M, Meisel E. Histochemistry of hepatic phosphatases at physiological pH with special reference to demonstration of bile canaliculi. Am J Clin Pathol 1957;27:13-23.
22. Gomori G. Histochemistry of enzymes in tissue sections. Am J Clin Pathol 16, Technical section 1946;7:77-85.
23. Tatematsu M, Mera Y, Inoue T, Satoh K, Ito N. Stable phenotypic expression of glutathione-S-transferase placental type and unstable phenotypic expression of γ-glutamyl transferase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis 1988;9:215-20.
24. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
25. Utley HC, Burnheim E, Hochestein P. Effect of sulfhydryl agents on peroxidation in microsomes. Arch Biochem Biophys 1967;118:29-32.
26. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-394.
27. Carlberg I, Mannervik B. Glutathione reductase. In: Meister A, ed. Methods in enzymology. vol. 113. Orlando, Florida: Academic Press, 1985. p 484-90.
28. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Biochemical role as a component of glutathione peroxidase. Science 1973;179:588-90.
29. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
30. Tabor H, Mehler AH. Enzymes of protein metabolism, histidase and urocanase. In: Colowick SP, Kaplan HO, eds. Methods in enzymology. vol. 2. New York: Academic Press, 1955. p 615-32.
31. Horowitz MH, Fling M, Horn E. Tyrosinase. In: Tabor H, Tabor CW, eds. Methods in enzymology. vol 17. New York: Academic Press, 1970. p 615-32.
32. Serpi R, Piispala J, Jarvilehto M, Vahakangas K. Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene DNA adducts as TPA in mouse skin. Carcinogenesis 1999;20:1755-60.
33. Singh NP, Mecony MT, Tice RR, Schneider EL. A simple technique of quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
34. Tice RR, Aguvell E, Anderson D, Burlinson B, Hartmann A, Keboyashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki Y. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutat 2000;35:206-21.
35. Snedecar GW, Cochran WG. One-way classification: analysis of variance. In: Statistical methods. 6th ed. Ames, Iowa: Iowa State University Press, 1967. p 258-96.
36. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
37. Wynder EL, Leveille GA, Weisburger JH, Livingston GE. Environmental aspects of cancer: the role of macro and micro components of foods. Westport, Connecticut: Food and Nutrition Press, 1983.
38. Ames BN. Dietary carcinogens and anticarcinogen, oxygen radicals and degenerative diseases. Science 1983;221:1256-64.
39. Conti CJ, Aldaz CM, Connell JO. Aneuploidy an early event in skin tumor development. Carcinogenesis 1986;7:1845-8.
40. Aldaz CM, Conti CJ, Larcher F. Sequential development of aneuploidy precedes keratin modification and γ-glutamyl transpeptidase expression in mouse skin papillomas. Cancer Res 1988;48:3253-9.
41. Colburn NH, Shigeko L, Rebecca H. Decrease of epidermal histidase activity by tumor promoting phorbol esters. Cancer Res 1975;35:3154-9.
42. Suran A, Spinola M, Pazzaglia S, Peissel B, Tiverson C, Tatangelo L, Mancuso M, Covelli V, Givonnelli L, Pitozzi V, Pignatiello C, Milani S. et al. Loss of tyrosinase activity confers increased skin tumor susceptibility in mice, Oncogene 2004;23:4130-5.
43. Sun Y. Free radicals, antioxidants enzymes, and carcinogenesis. Free Radical Biol Med 1990;8:583-99.
44. Buzard GS. Studies of oncogene activation and tumor suppressor gene inactivation in normal and neoplastic rodent tissue, Mutation Res 1996;365:43-58.
45. Ansari KM, Chauhan LKS, Dhawan A, Khanna SK, Das M. Unequivocal evidence of genotoxic potential of argemone oil in mice. Int J Cancer 2004;112:890-5.
46. Stiborova M, Simerek V, Frei E, Hobza P, Ulrichova J. DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids, sanguinarine and chelerythrine as revealed by the 32p- postlabeling technique. Chem Biol Int 2002;140:231-42.
47. El Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogeslstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
48. Belyaeva TN, Sedova VM, Feddeeva, MD. Study of the inhibition of DNA hydrolysis and RNA synthesis by alkaloid, sanguinarine. Biokhimiya (Moscow) 1984;49:222-9.
49. Moerman CJ, De-Mesquita HBB, Smeets FWM, Runia S. Consumption of foods and micronutrients and the risk of cancer of the biliary tract. Preventive Med 1995;24:591-602.
50. Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I. Allele specific mutations involved in the pathogenesis of endemic T1. Allele specific mutations involved in the pathogenesis of gall bladder cancer in Chile. Cancer Res 1995;55:2511-5.
51. Wistuba II, Gazdar AF, Rao I, Albrose-Saavedra J. p53 protein over expression in gall bladder carcinoma and precursor lesion: an immunohistochemical study. Hum Pathol 1996;27:360-5.